Ledger.Open graph →
SEC Form D · filed October 19, 2023

Akari Therapeutics Plc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(c)
Industry
Other Health Care
Location
BOSTON, MA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (18)

Michael Grissinger · Boston, MADirectorRachelle Jacques · Boston, MAExec · DirectorWendy Dicicco · Boston, MAExecDr. Ray Prudo · Boston, MADirectorDonald Williams · Boston, MADirectorWa'El Hashad · Boston, MADirectorDonald Williams · Boston, MADirectorMichael Grissinger · Boston, MADirectorWendy Dicicco · Boston, MAExecDr. Ray Prudo · Boston, MADirectorRachelle Jacques · Boston, MAExec · DirectorWa'El Hashad · Boston, MADirectorBrian Derrick · NEW YORK, NYDirectorTaylor Ourada · NEW YORK, NYExecColin T. Mackay · Grand Cayman, Cayman IslandsDirectorMaxwell Deibel · Boca Raton, FLExec · DirectorJustin Cooper · Boca Raton, FLDirectorChad M. Hagler · RALEIGH, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗